Bacteriostatic Water for Semaglutide Research: Specification and Protocol Guide
Bacteriostatic water is the standard diluent for reconstituting lyophilized GLP-1 receptor agonist peptides in the lab. Three numbers explain why: 0.9% benzyl alcohol as the bacteriostatic agent, a pH range of 5.0–7.0, and an endotoxin limit of <0.5 EU/mL under USP <71>. Together they preserve semaglutide research peptide integrity through multi-dose withdrawal while holding sterility across the 28-day post-reconstitution window that most peptide workflows run on. For research-grade supply with per-lot Certificate of Analysis verification, see BAC Water Depot's 10 mL vial catalog.
Why Bacteriostatic Water Is the Standard Semaglutide Research Diluent
A semaglutide diluent has to do three things at once: keep the peptide stable, keep the vial sterile across repeated access, and stay chemically compatible with the GLP-1 structure. Semaglutide reconstitution research protocols demand all three, balanced together. Bacteriostatic water clears the bar through three formulation parameters that set it apart from the alternatives, and each one earns its place for a distinct reason.
Start with the preservative. The 0.9% benzyl alcohol inhibits microbial proliferation without denaturing the semaglutide peptide backbone. Sterile water for injection (SWFI) has no such capacity; it lacks preservative and is single-use under USP guidelines, discarded after one access. Bacteriostatic water holds sterility across multiple withdrawals from the same vial over a 28-day period. That property matters in peptide research, where dose titration studies, pharmacokinetic sampling, and replicate experiments all demand repeated access to the same reconstituted stock solution. The benzyl alcohol concentration stays low enough to leave semaglutide's tertiary structure alone while still delivering robust antimicrobial activity against common laboratory contaminants — Staphylococcus epidermidis, Escherichia coli, and Candida albicans — per USP <51> antimicrobial effectiveness testing criteria.
Then there's pH. The 5.0–7.0 specification for research-grade bacteriostatic water tracks semaglutide's stability profile closely. GLP-1 receptor agonists demonstrate optimal structural integrity inside that window, where the peptide's 31 amino acid sequence maintains proper folding and disulfide bond configuration. Drop below pH 5.0 and you invite acid-catalyzed hydrolysis of peptide bonds, particularly at aspartate and glutamate residues. Push above pH 7.0 and deamidation of asparagine and glutamine side chains accelerates. Labs running semaglutide reconstitution research should verify the pH spec on each lot's Certificate of Analysis to confirm compatibility with their own experimental protocol.
Endotoxin control is the third dividing line between research-grade water and cheaper stock. The USP <71> limit of <0.5 EU/mL keeps lipopolysaccharide out of cellular assays, receptor binding studies, and in vitro pharmacology work on semaglutide peptides. Demand third-party verification by Limulus Amebocyte Lysate (LAL) testing, documented on lot-specific CoAs. BAC Water Depot tests endotoxin across three independent laboratories, with results consistently below 0.25 EU/mL — a margin that satisfies stringent institutional procurement. Per FDA 21 CFR 809.10 labeling rules for laboratory reagents, every vial carries explicit research-use-only designation for compliance inside institutional research settings.
One more parameter shapes diluent selection: the container. USP Type I borosilicate glass exhibits minimal ion leaching and stays chemically inert across the typical 2-year shelf life of an unopened bacteriostatic water vial. Inferior glass types risk alkaline dissolution that raises pH beyond semaglutide's stability range, while plastic containers introduce plasticizer leachates that may interact with hydrophobic peptide regions. The 10 mL fill volume in Type I borosilicate glass accommodates the standard 2 mg, 5 mg, and 10 mg lyophilized semaglutide research peptide quantities commonly supplied by peptide synthesis vendors, leaving adequate headspace for mixing and withdrawal operations.
Critical Specification Parameters for Semaglutide Reconstitution Research
| Parameter | Specification | Analytical Method | Quality Impact | |-----------|--------------|-------------------|----------------| | pH | 5.0–7.0 | USP <791> | Peptide stability, prevents hydrolysis/deamidation | | Benzyl Alcohol | 0.9% w/v | Gas chromatography | Bacteriostatic efficacy, multi-dose sterility | | Endotoxin | <0.5 EU/mL | LAL kinetic chromogenic | Assay validity, prevents immune artifact | | Sterility | Sterile | USP <71> | Contamination prevention, data integrity | | Particulates | Class 100 | USP <788> | Optical clarity, injection compatibility | | Container | Type I borosilicate | USP <660> | Chemical inertness, pH stability |
Verify all six parameters on each lot's Certificate of Analysis before you initiate reconstitution protocols. The pH line deserves the closest look in GLP-1 peptide research, because semaglutide degrades on a pH-dependent curve that steepens outside the range. Published peptide stability data show semaglutide holding >95% purity over 28 days at 2–8°C when reconstituted in diluents maintaining pH 5.5–6.5; formulations drifting to pH 4.5 or pH 7.5 show 8–12% degradation over the same period. Research facilities running time-course experiments or longitudinal dosing studies should verify both the initial diluent pH and the post-reconstitution solution pH using calibrated laboratory pH meters accurate to ±0.02 units.
Benzyl alcohol concentration sets the bacteriostatic window for the reconstituted solution. The 0.9% w/v spec acts against vegetative bacteria and fungi while staying under the 2% threshold tied to protein precipitation or aggregation. Gas chromatography on lot-specific CoAs confirms batch-to-batch consistency — a real concern for independent researchers who stock vials from several lots and need uniform behavior. Under 0.8% and sterility maintenance during multi-dose access slips; over 1.0% and you may shift semaglutide solubility or add preservative interference to some receptor binding assays.
Endotoxin belongs to kinetic chromogenic LAL testing, not gel-clot. Chromogenic gives a quantitative EU/mL value; gel-clot gives binary pass/fail. Research-grade water for semaglutide should sit below 0.25 EU/mL consistently — margin against the USP <71> limit of <0.5 EU/mL. That headroom earns its keep when reconstituted semaglutide is diluted further for cellular or receptor work, where cumulative endotoxin from every reagent must stay under the assay's threshold. Labs doing biomedical research with primary cultures or organoids should verify source-water endotoxin as routine: lipopolysaccharide at levels as low as 0.1 EU/mL can fire inflammatory signaling that wrecks GLP-1 receptor pharmacology.
Particulate matter under USP <788> protects optical clarity and prevents physical instability in reconstituted semaglutide solutions. Class 100 cleanroom manufacturing conditions limit particulates >10 μm to <25 per container and >25 μm to <3 per container. Semaglutide research never involves injection into living subjects under the research-use designation, yet particulate control still matters: stray particles seed nucleation sites that trigger peptide aggregation during storage. Inspect both the diluent before use and the reconstituted semaglutide solution after mixing — that visual check is a quality checkpoint. Any visible haze, turbidity, or particulate matter warrants rejection of the vial and investigation of storage or handling conditions.
Container verification through USP <660> glass testing confirms Type I borosilicate composition with minimal extractables. Lower-specification soda-lime glass containers leach sodium ions that elevate pH over time, while certain plastic containers introduce phthalate plasticizers that partition into hydrophobic peptide regions. The 10 mL vial format in Type I borosilicate glass provides optimal geometry for standard semaglutide reconstitution volumes: a 2 mg lyophilized peptide quantity typically reconstitutes in 2.0 mL bacteriostatic water to yield a 1.0 mg/mL working concentration, leaving adequate headspace in the 10 mL vial for mixing and withdrawal operations without excessive air exposure.
Research Peptide Semaglutide Preparation: Step-by-Step Reconstitution Protocol
Technique drives reproducibility. Reconstitute carefully and your concentration holds across replicates; rush it and the peptide pays. The protocol below reflects standard operating procedures for peptide reconstitution in the lab.
Step 1: Environmental preparation. Work inside a Class II biological safety cabinet or laminar flow hood at ISO Class 5 (Class 100) air quality. Let the lyophilized semaglutide vials and the bacteriostatic water vials reach room temperature (20–25°C) for 15–20 minutes before opening. Equilibration stops condensation forming inside the vial when the stopper is penetrated, which lowers contamination risk and keeps volume measurement accurate during diluent addition.
Step 2: Diluent volume calculation. Set the bacteriostatic water volume from the lyophilized mass and target concentration. For 2 mg intended at 1.0 mg/mL, add 2.0 mL. For 5 mg, add 5.0 mL for 1.0 mg/mL or 2.5 mL for 2.0 mg/mL. Above 2.0 mg/mL you risk incomplete dissolution or aggregation; below 0.5 mg/mL you may approach solubility limits, depending on buffer composition and storage duration.
Step 3: Diluent addition technique. Withdraw the calculated volume with a sterile 3 mL or 5 mL syringe on an 18-gauge or 20-gauge needle. Penetrate the lyophilized vial's stopper at 45 degrees and run the stream down the vial wall — never straight onto the cake. Gentle addition prevents the foaming and shearing that denature peptide. Add slowly over 10–15 seconds, then pull the needle without pushing extra air into the headspace.
Step 4: Dissolution without agitation. Let passive diffusion dissolve the cake for 60–90 seconds. Do not shake, vortex, or invert. Those actions create air-liquid interfaces and mechanical stress that drive aggregation and oxidation. If particulates remain past 90 seconds, swirl the vial gently in a horizontal circle for 5–10 seconds, then wait another 30 seconds. The finished solution should look clear and colorless to faintly opalescent — no visible particulates, no turbidity.
Step 5: Post-reconstitution verification. Log the reconstitution date, calculated concentration, both lot numbers (peptide and diluent), and any notes on dissolution time or appearance in the notebook or electronic data system. Label the vial with the same details plus a 28-day expiration tied to the bacteriostatic window. If the protocol calls for pH documentation, check it on a calibrated meter — properly reconstituted semaglutide in bacteriostatic water reads pH 5.5–6.5.
Step 6: Storage conditions. Move the solution straight to 2–8°C refrigeration, protected from light. Amber glass or aluminum foil wrapping handles photostability through multi-dose access. Never freeze it; freeze-thaw cycles drive aggregation and loss of activity. If the protocol needs aliquots, split them within 2 hours of reconstitution using sterile technique in the cabinet, then store at 2–8°C under the same 28-day guideline.
Run this way, the six-step protocol carries semaglutide research peptide from lyophilized storage through reconstitution and multi-dose access intact. Research facilities should validate the procedure against their specific semaglutide source and experimental conditions, documenting dissolution times, solution clarity, and stability over the intended storage period. Unexpected dissolution behavior or visible precipitation during storage may indicate peptide degradation, diluent incompatibility, or contamination requiring investigation.
Which BAC Water Depot SKU fits this use case?
Monthly semaglutide research program (4–8 reconstitutions/month): 10-pack ($74.99 · $7.49/vial) provides 100 mL total capacity with cost efficiency for routine workflows.
Institutional laboratory or CRO setting (15+ reconstitutions/month): 25-pack ($174.99 · $6.99/vial) reduces per-reconstitution cost while maintaining lot consistency.
High-throughput screening or multi-site studies: Bulk program from $6.49/vial with custom lot reservations ensures specification uniformity across large experiments.
Certificate of Analysis Verification: What to Check Before Purchase
Every lot used for semaglutide reconstitution should arrive with a Certificate of Analysis documenting third-party verification of the critical parameters. Procurement managers and principal investigators should confirm these CoA elements before accepting delivery and starting experimental use.
Lot number traceability. The CoA must show a unique lot or batch number matching the vial label. That link lets you trace any quality deviation or experimental anomaly back to a specific batch and run root-cause analysis. Labs doing institutional procurement should archive CoAs indexed by lot for compliance documentation and audit trails. Expect a consistent format — say, BW-2026-127 — that encodes production date or sequence for inventory management.
pH testing results. The CoA should report measured pH, not a bare pass/fail. Look for something like "pH 5.7 (specification: 5.0–7.0)" with the method named — typically USP <791> determination by calibrated meter. Values clustered in the 5.5–6.5 range signal tight process control and predict good semaglutide stability. Lots reading near the limits (pH 5.1, pH 6.9) stay compliant but carry less margin and warrant closer monitoring in storage.
Benzyl alcohol content. The CoA should document benzyl alcohol percentage by gas chromatography with flame ionization detection (GC-FID) or an equivalent validated method. Expect a measured value against a range — "0.90% w/v (specification: 0.85–0.95%)" or similar. Verification heads off two failure modes: under-spec that erodes bacteriostatic efficacy, and over-spec that may shift solubility or add preservative interference. Labs using bacteriostatic water across several peptide types should keep this documentation per lot for cross-reference when an assay misbehaves.
Endotoxin testing data. The CoA must carry quantitative LAL results in EU/mL. Look for "<0.10 EU/mL (specification: <0.5 EU/mL)" — compliance plus margin against the USP <71> limit. The method should be named; kinetic chromogenic LAL beats gel-clot for low-endotoxin verification. CRO laboratory and contract research operations should confirm the testing came from an independent third-party lab rather than the manufacturer's own bench, which adds assurance for client reporting.
Sterility test results. The CoA should document sterility per USP <71> using both fluid thioglycollate medium (anaerobes and aerobes) and soybean-casein digest medium (fungi and aerobes), each at 14-day incubation. Both should state "No growth observed." Stronger CoAs add negative-control documentation and incubation temperature records — 30–35°C for thioglycollate, 20–25°C for soybean-casein — showing testing rigor. Sterility testing covers batch release; aseptic technique at the bench still falls to you, since the bacteriostatic agent maintains sterility but cannot sterilize a contaminated environment.
Particulate matter analysis. The CoA should report counts for both >10 μm and >25 μm ranges per USP <788> light obscuration testing. Expect numbers well under the limits — "<5 particles >10 μm per container (limit: 25)" and "<1 particle >25 μm per container (limit: 3)" for the 10 mL format. Consistently low counts mean robust cleanroom control and low risk of nucleation-driven aggregation while the reconstituted solution sits in storage.
BAC Water Depot ships a per-lot Certificate of Analysis with every order, documenting all six parameters across three independent testing laboratories. Each CoA carries the ISO 9001:2015 registration number of the manufacturing facility, tying the lot to its quality management system. Labs needing more for institutional compliance can request expanded CoAs — method validation summaries, calibration records, analyst credentials — through the research reference program. Those packages support regulatory audits, grant reporting, and supplementary materials for publications involving semaglutide research peptides.
GLP-1 Research Diluent Compatibility: Bacteriostatic Water vs. Alternatives
Some semaglutide reconstitution research protocols weigh alternative diluents based on experimental requirements, cost constraints, or availability. Understanding the trade-offs between bacteriostatic water and the alternatives lets you choose deliberately for a specific application rather than by default.
Bacteriostatic water vs. sterile water for injection (SWFI). Sterile water for injection is a preservative-free option for single-dose reconstitution where the whole vial gets used within 4–6 hours. It has a theoretical edge when benzyl alcohol might interfere with a specific assay — certain mass spectrometry ionization conditions, or enzymatic assays where preservative molecules could inhibit catalysis. The catch: no bacteriostatic capacity, so any unused reconstituted solution gets discarded after each access. That wastes peptide and raises cost. For dose titration, pharmacokinetic time courses, or replicate work needing multiple withdrawals from one stock, the 28-day multi-dose window wins on operational efficiency. The 0.9% benzyl alcohol shows no interference with standard GLP-1 receptor binding assays, cell viability assays, or HPLC purity analysis in published peptide methodology.
Bacteriostatic water vs. bacteriostatic saline. Bacteriostatic saline (0.9% sodium chloride with 0.9% benzyl alcohol) adds isotonicity that can help cell culture work where osmotic stress would confound results. The cost is ionic strength: 154 mM sodium chloride shifts semaglutide aggregation kinetics and solubility versus the low-ionic-strength environment of plain bacteriostatic water. Research focused on peptide structure, stability, or formulation development should favor bacteriostatic water to keep ionic interactions out of the picture. Saline earns its place when reconstituted semaglutide goes straight into a physiological buffer for cellular assays, where the assay buffer — not the diluent — sets final ionic strength. For the common workflow of stock prep, aliquoting, and storage, bacteriostatic water holds stability better and precipitates less in refrigerated storage.
Bacteriostatic water vs. DMSO or other organic diluents. Dimethyl sulfoxide (DMSO) and solvents like propylene glycol or acetic acid solutions show up in protocols for hydrophobic peptides with poor aqueous solubility. Semaglutide does not need them. Despite its hydrophobic residues, it dissolves adequately in neutral-pH aqueous systems with no organic cosolvent. DMSO permeabilizes cell membranes, confounding uptake studies and altering receptor trafficking — wrong for GLP-1 pharmacology. Acetic acid drops pH, which can briefly aid solubility for some peptides but accelerates acid-catalyzed degradation of semaglutide over the multi-day span of a typical protocol. Neutral, aqueous bacteriostatic water matches semaglutide's physiological environment and published stability data, making it the first-choice diluent.
Bacteriostatic water vs. deionized or distilled water. Deionized water and distilled water look superficially similar but lack both sterility assurance and bacteriostatic preservation — disqualifying for semaglutide reconstitution. Deionized water can carry viable bacteria, endotoxin, and particulates that compromise data and invite contamination during multi-dose access. Distilled water runs purer on dissolved ions yet has no USP monograph spec for sterility, endotoxin, or pH, all of which govern peptide stability. Neither goes through the sterile filtration, fill, and terminal sterilization that define USP-grade bacteriostatic water manufacturing. Order bacteriostatic water for injection (BWFI) by name — not generic "bacteriostatic water" — to ensure USP-compliant material fit for semaglutide research peptide reconstitution.
Bacteriostatic water vs. Ringer's solution or buffered diluents. Ringer's solution and other buffered physiological solutions add ionic species and pH buffering that help some applications but complicate any clean stability assessment. The calcium, potassium, and chloride in Ringer's drive ionic-strength effects on peptide conformation and solubility, while phosphate or acetate buffers elsewhere can catalyze oxidation or deamidation depending on buffer pKa and the peptide microenvironment. For fundamental stability studies or formulation development, the simple composition of bacteriostatic water — water plus 0.9% benzyl alcohol — strips out confounding variables and lets you read peptide behavior directly. Buffered diluents fit when reconstituted semaglutide needs immediate pH adjustment to specific assay conditions; even then, reconstituting first in bacteriostatic water and diluting into buffer afterward gives tighter control over pH progression and shields the peptide from destabilizing buffer components during the critical dissolution phase.
Across every comparison, the analysis consistently identifies bacteriostatic water as the optimal general-purpose diluent for semaglutide reconstitution research. The alternatives stay reserved for specialized applications where a defined property addresses a defined experimental requirement. Research facilities establishing standard operating procedures for GLP-1 peptide work should designate bacteriostatic water as the default diluent, with any alternative choice requiring scientific justification documented in the experimental protocol.
Storage and Handling Best Practices for Reconstituted Semaglutide Research Solutions
Good storage and handling stretch the usable life of a reconstituted solution and keep data consistent across replicates. The practices below reflect established principles for peptide research workflows.
Temperature control. Store reconstituted semaglutide solutions at 2–8°C immediately following preparation and hold that temperature throughout the 28-day bacteriostatic preservation window. Do not freeze. Ice crystal formation during freezing concentrates peptides and excipients in the liquid channels between crystals, driving aggregation and precipitation. A single freeze-thaw cycle can reduce semaglutide recovery by 15–30% per published peptide stability data, with the extent of loss depending on peptide concentration, freezing rate, and storage duration. Dedicated laboratory refrigerators with temperature monitoring and alarm systems provide superior storage conditions compared to multi-user units subject to frequent door opening and temperature fluctuations. Log refrigerator temperatures daily or implement continuous data logging, so you can verify that conditions stayed within specification if experimental anomalies require investigation.
Light protection. Shield the solution from direct light with amber glass vials, aluminum foil, or opaque containers. Peptides carrying aromatic amino acids — tyrosine, tryptophan, phenylalanine — photodegrade under UV or short-wavelength visible light, generating oxidative damage and aggregation-prone species. Lab work happens indoors under standard lighting with little UV, but cumulative exposure across 28 days of multi-dose access still adds up. Amber Type I borosilicate vials build the protection in, no extra handling required.
Contamination prevention. Maintain aseptic technique on every withdrawal from reconstituted semaglutide vials: work in a biological safety cabinet, use a sterile needle and syringe for each access, and swab the rubber stopper with 70% isopropanol before needle penetration. Replace the needle between the diluent withdrawal step and the semaglutide step so you do not introduce contaminants from the diluent vial into the peptide solution. Limit air headspace exposure by keeping needle dwell time in the stopper short and avoiding unnecessary pressure-equalization steps that pull in room air. The 0.9% benzyl alcohol bacteriostatic agent inhibits microbial growth but does not kill organisms instantaneously; introduction of high bioburden through poor aseptic technique can overwhelm the preservative capacity and lead to visible contamination or endotoxin accumulation.
Access frequency limits. Bacteriostatic water preserves sterility for 28 days per USP guidelines, yet capping access at 10–15 withdrawals over that span lowers cumulative contamination risk and protects stopper integrity. Each penetration opens a possible leak path and slightly degrades the stopper's self-seal. Protocols needing >15 withdrawals from one concentration batch should aliquot the initial solution into several smaller vials within 2 hours of prep, each covering a subset of timepoints. You trade a little handling time for less contamination risk and better stopper integrity across the timeline.
Concentration verification. Confirm reconstituted semaglutide concentration by UV spectrophotometry or HPLC analysis at the beginning and end of the 28-day usage period to verify stability under your actual laboratory storage and handling conditions. Semaglutide exhibits characteristic UV absorption with a maximum near 280 nm from its tyrosine and tryptophan content, so you can determine concentration via a molar extinction coefficient or comparison to a reference standard curve. Agreement within ±5% between initial and final measurements confirms acceptable stability; larger deviations warrant investigation of storage conditions, handling procedures, or lot-specific quality issues. Facilities conducting biotech startup research or sports science applications should establish this concentration verification as standard practice to ensure data reproducibility.
Documentation and labeling. Label each reconstituted semaglutide vial with reconstitution date, expiration date (28 days post-reconstitution), final concentration, peptide lot number, diluent lot number, and operator initials. That information enables traceability if experimental anomalies occur and prevents inadvertent use of expired or incorrectly labeled solutions. Maintain parallel documentation in laboratory notebooks or electronic systems recording every withdrawal — date, volume, intended use, and any observations regarding solution appearance. This withdrawal log facilitates troubleshooting when results vary unexpectedly between timepoints and provides audit-trail documentation for institutional compliance or publication data-availability requirements.
Followed together, these storage and handling practices minimize semaglutide degradation, aggregation, and contamination across the multi-dose access period, preserving research data quality and letting you interpret experimental results with confidence. Limit any deviation to a scientifically justified experimental requirement, and document it as a protocol amendment.
Common Mistakes to Avoid
- Vortexing or shaking during reconstitution. Mechanical agitation introduces air-liquid interfaces and shear forces that denature peptides and promote aggregation. Use gentle swirling only after 60–90 seconds of passive dissolution.
- Freezing reconstituted semaglutide solutions. Freeze-thaw cycles cause ice-induced concentration gradients and peptide aggregation, reducing recovery by 15–30% per cycle. Maintain refrigerated storage at 2–8°C exclusively.
- Using expired bacteriostatic water. Expired diluent may exhibit pH drift due to carbon dioxide absorption, benzyl alcohol degradation, or compromised sterility. Verify expiration dates on both diluent and reconstituted peptide before use.
- Reconstituting in non-sterile environments. Room air contains particulate matter and microbial contaminants that introduce endotoxin and bioburden. Perform all reconstitution steps within a Class II biological safety cabinet or ISO Class 5 laminar flow hood.
- Mixing peptide lots or diluent lots. Combining materials from different production batches prevents traceability if quality issues arise and introduces uncontrolled lot-to-lot variability. Use a single diluent lot per reconstitution and record both lot numbers.
People Also Ask
How long is reconstituted semaglutide stable for research use?
Reconstituted semaglutide research solutions are typically held for up to 28 days under continuous refrigeration at 2–8°C. The bacteriostatic water's benzyl alcohol suppresses microbial growth across repeated stopper punctures over that window; the peptide's own stability, not the diluent, is the limiting factor.
Why use bacteriostatic water instead of sterile water for semaglutide reconstitution?
Bacteriostatic water carries 0.9% benzyl alcohol, a preservative that keeps a multi-dose vial usable across repeated withdrawals. Plain sterile water for injection has no preservative, so its usable window after the first puncture is far shorter — which is why bacteriostatic water is the standard for multi-timepoint research.
What concentration of benzyl alcohol does bacteriostatic water contain?
0.9% benzyl alcohol by volume, equal to 9 mg per mL — the USP specification for multi-dose container preservation. That level provides bacteriostatic activity without denaturing the peptide at typical reconstitution dilutions.
Can reconstituted semaglutide research solutions be frozen?
No. Freeze-thaw cycles drive ice-induced concentration gradients and aggregation that reduce recovery by roughly 15–30% per cycle. Hold reconstituted solutions at 2–8°C and aliquot if smaller working portions are needed.
What should a Certificate of Analysis confirm before purchase?
A per-lot CoA should document sterility (USP <71>), endotoxin within specification, the benzyl alcohol concentration, and pH — tied to the specific lot you receive. Per-lot testing reflects the actual material in hand, which a generic spec sheet does not.
How much bacteriostatic water should be used to reconstitute semaglutide for research?
The volume sets the final concentration (mass of peptide ÷ volume of water). Choose it to match the resolution of your measuring device rather than a fixed habit; a larger volume yields a more dilute, easier-to-measure solution.
About BAC Water Depot: Research-grade bacteriostatic water for qualified research institutions and laboratory buyers. ISO 9001:2015 registered US facility, verified by three independent testing laboratories, per-lot Certificate of Analysis. Same-day US shipping before 2pm ET. Card, Apple Pay, Venmo, and Zelle accepted — instructions arrive by email after checkout. Browse the catalog → · For research and laboratory use only — not for human or veterinary use.
Last reviewed: 2026-06-07
